Prescribing Information
En Español
What do the Experts Say?
Tell A Friend
Find a pharmacy near you by entering your zip code
 

References

  1. ACOG steps up efforts to get emergency contraception to women. May 8, 2006. The American College of Obstetricians and Gynecologists. http://www.acog.org/from_home/publications/press_releases/
    nr05-08-06-1.cfm. Accessed February 25, 2008.
  2. Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health. 2002;34:294-303.
  3. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 1998;352:428-433.
  4. Food and Drug Administration. Center for Drug Evaluation and Research Application Number: NDA21045. www.fda.gov/cder/foi/nda/99/21-045_Plan%20B_medr.pdf. Accessed March 10, 2008.
  5. Kavanaugh ML, Schwarz EB. Counseling about the use of emergency contraception in the United States. Perspect Sex Reprod Health. 2008;40(2):81-86.
  6. The Emergency Contraception Website. Types of emergency contraception. Emergency contraceptive pills worldwide. http://ec.princeton.edu/questions/dedicated.html.
    Accessed February 25, 2008.
  7. Hamoda H, Ashok PW, Stalder C, Flett GMM, Kennedy E, Templeton A. A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstet Gynecol. 2004;104(6):1307-1313.
  8. von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002;360(9348):1803-1810.
  9. Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception. 2002;66(4):269-273.
  10. Emergency contraception. November 2005. The Henry J. Kaiser Family Foundation: Women’s Health Policy. http://www.kff.org/womenshealth/3344-03.cfm.
    Accessed February 25, 2008.
  11. Emergency contraceptive pills. February 2004. The Henry J. Kaiser Family Foundation: Women’s Health Policy. http://www.kff.org/womenshealth/3344-02.cfm.
    Accessed February 25, 2008.

Important Safety Information

Next Choice® should not be used by women with a known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice should be evaluated for ectopic pregnancy. Next Choice is not effective in terminating an existing pregnancy, and does not protect against STI/HIV. Next Choice may alter the next expected menses, however, if menses is delayed beyond 1 week, pregnancy should be considered. The most common adverse reactions in the clinical trial were menstrual changes (26%), nausea (23%), abdominal pain (18%), fatigue (17%), headache (17%), dizziness (11%), and breast tenderness (11%).

To report side effects of prescription drugs to the FDA, visit fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Next Choice, please call our Medical Communications Department at 866-9WATSON.

This Web site is intended for United States Prescribers, Pharmacists & Consumers.